What you should know:
1. The new clearance covers new system instrumentation and an updated surgical technique.
2. The FDA initially cleared the device in October 2018.
3. SpineEX expects to begin offering the Sagittae system commercially by the end of March.
4. SpineEX CEO and Chairman Roy Chin said, “We expect, in the very near future, to announce the first procedure using our innovative Sagittae device to be performed by a leading orthopedic surgeon and complete our transition from a development stage to a commercial stage and revenue generating company.”
More articles on devices:
The spine surgery devices, techniques that won’t stand the test of time
How spine surgeons view consolidation in healthcare
4 spine, neurosurgeons on the move in February
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
